Cargando…

Bevacizumab as Single Agent in Children and Teenagers with Optic Pathway Glioma

SIMPLE SUMMARY: Nowadays, there is no univocal therapeutical care for children with optic pathway gliomas (OPG): different chemotherapy regimens are proposed, but no one has clearly proved its superiority over the others on the PFS (Progression free survival). The efficacy of bevacizumab, an anti-VE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calò, Pierluigi, Pianton, Nicolas, Basle, Alexandre, Vasiljevic, Alexandre, Barritault, Marc, Beuriat, Pierre Aurélien, Faure-Conter, Cécile, Leblond, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954224/ https://www.ncbi.nlm.nih.gov/pubmed/36831379 http://dx.doi.org/10.3390/cancers15041036

Ejemplares similares

Cerebellar lesions at a young age predict poorer long-term functional recovery
por: Beuriat, Pierre-Aurélien, et al.
Publicado: (2020)

Brainstem tumors in children: a monocentric series in the light of genetic and bio-molecular progress in pediatric neuro-oncology
por: Boukaka, Rel Gerald, et al.
Publicado: (2023)

Growth Hormone Replacement Therapy Seems to Be Safe in Children with Low-Grade Midline Glioma: A Series of 124 Cases with Review of the Literature
por: Puvilland, Coline, et al.
Publicado: (2022)

EPCT-11. PHASE 1 STUDY OF FLUVASTATIN-CELECOXIB COMBINATION IN CHILDREN WITH RELAPSING/REFRACTORY OPTICO-CHIASMATIC LOW-GRADE GLIOMA OR HIGH-GRADE GLIOMAS (FLUVABREX): FINAL RESULTS
por: Andrew, Nicolas, et al.
Publicado: (2020)

Pediatric Low-Grade Glioma Surgery with Sodium Fluorescein: Efficient Localization for Removal and Association with Intraoperative Pathological Sampling
por: de Laurentis, Camilla, et al.
Publicado: (2022)

Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
por: Leblond, Pierre, et al.
Publicado: (2023)

Central nervous system germ cell tumor, an archetypal AYA tumor and a model for pediatric and neuro-oncology collaboration, review from the EURACAN domain 10 group
por: Faure Conter, Cecile, et al.
Publicado: (2022)

The shifting role of the cerebellum in executive, emotional and social processing across the lifespan
por: Beuriat, Pierre-Aurélien, et al.
Publicado: (2022)

A rare case of giant multiseptated thoracic myelomeningocele with segmental placode: Commentary
por: Beuriat, Pierre-Aurelien, et al.
Publicado: (2016)

Progression of myopia in teenagers and adults: a nationwide longitudinal study of a prevalent cohort
por: Ducloux, Alexandre, et al.
Publicado: (2023)

An Overview of Fotemustine in High-Grade Gliomas: From Single Agent to Association with Bevacizumab
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma(†)
por: Nagane, Motoo, et al.
Publicado: (2012)

Miniature Optical Particle Counter and Analyzer Involving a Fluidic-Optronic CMOS Chip Coupled with a Millimeter-Sized Glass Optical System †
por: Jobert, Gabriel, et al.
Publicado: (2021)

Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy
por: Rakotonjanahary, Josué, et al.
Publicado: (2015)

Improving Teenagers’ Divergent Thinking With Improvisational Theater
por: Hainselin, Mathieu, et al.
Publicado: (2018)

GCT-48. OUTCOME OF CNS MALIGNANT NON-GERMINOMATOUS GERM CELL TUMORS (GCT) WITH AFP > 1000 ng/ml AT DIAGNOSIS TREATED ACCORDING TO SIOP CNS GCT 96
por: Calaminus, Gabriele, et al.
Publicado: (2020)

The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles’ Heel
por: Huchedé, Paul, et al.
Publicado: (2022)

Recent Update in Pharmacological Agents for Optic Pathway Glioma
por: Park, Meerim
Publicado: (2022)

A New Insight on the Role of the Cerebellum for Executive Functions and Emotion Processing in Adults
por: Beuriat, Pierre-Aurélien, et al.
Publicado: (2020)

Evidence of the role of the cerebellum in cognitive theory of mind using voxel-based lesion mapping
por: Beuriat, Pierre-Aurélien, et al.
Publicado: (2022)

Metopic triangle osteotomy in trigonocephaly Piezosurgery: a technical variant to control metopic emissary veins
por: Licci, Maria, et al.
Publicado: (2021)

Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma
por: Cha, Yongjun, et al.
Publicado: (2017)

Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors
por: Brindel, Aurélien, et al.
Publicado: (2020)

Progression of myopia in children and teenagers: a nationwide longitudinal study
por: Tricard, Dorian, et al.
Publicado: (2022)

Integrin Inhibitor Suppresses Bevacizumab-Induced Glioma Invasion()()
por: Ishida, Joji, et al.
Publicado: (2014)

Delivery of bevacizumab by intracranial injection: assessment in glioma model
por: Liu, Yu-Xiao, et al.
Publicado: (2018)

Bevacizumab in Recurrent Glioma: Patterns of Treatment Failure and Implications
por: Li, Yi, et al.
Publicado: (2017)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma
por: Nagpal, Seema, et al.
Publicado: (2015)

Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low‐grade glioma
por: Zhukova, Nataliya, et al.
Publicado: (2018)

Important functional distress in a teenager with optic nerve drusen
por: Lazar, Alina Simona, et al.
Publicado: (2019)

Teenagers /
por: Lewis, Gordon
Publicado: (2007)

ReGeneraTing Agents (RGTA (®)) are a new option to improve amputation outcomes in the recovery of severe hand injuries
por: Ahmad, Roohi Sharifah, et al.
Publicado: (2018)

Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients
por: Boydell, Emma, et al.
Publicado: (2019)

Activity and Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant Gliomas
por: Vaccaro, V., et al.
Publicado: (2014)

Disease progression patterns of bevacizumab responders with recurrent malignant gliomas
por: Kim, Ju-Hwi, et al.
Publicado: (2017)

COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA
por: Tsukamoto, Yoshihiro, et al.
Publicado: (2019)

COT-22 TIMING OF SURGERY AND BEVACIZUMAB THERAPY FOR MALIGNANT GLIOMAS
por: Matsubara, Toshio, et al.
Publicado: (2019)

Pretreatment inflammatory indices predict Bevacizumab response in recurrent Glioma
por: Martínez-González, Alicia, et al.
Publicado: (2020)

Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial
por: Cohen, Adam L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d7ar800lspc7k91d3jijrho6ei